AI assistant
Organogenesis Holdings Inc. — Director's Dealing 2021
Feb 17, 2021
32756_dirs_2021-02-16_9bd93632-a96d-4a66-a62d-d7c9f940059b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Organogenesis Holdings Inc. (ORGO)
CIK: 0001661181
Period of Report: 2021-02-11
Reporting Person: NUSSDORF GLENN H (Director, 10% Owner)
Reporting Person: Wisdom Starr (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-11 | Class A Common Stock | S | 200000.0 | $3.25 | Disposed | 68594976.0 | Direct |
Footnotes
F1: The reported securities sold were held directly by Alan A. Ades, who is a member of the Group (as defined below). On November 17, 2020, Mr. Ades purchased shares of Class A common stock of Organogenesis Holdings Inc. at a price of $3.25 per share, including (i) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of one of his sons and (ii) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of an entity that is managed by Mr. Ades' son-in-law. This Form 4 reflects the sales of such shares.